Redeye: Heliospectra - Transitional Year
Redeye is still optimistic about Heliospectra and the prospects for its new strategic direction as a system supplier within Smart Farming. 2022 is described as a transitional year, including refocus of the organization and finalizing some important development projects for the new customer offering. Fortunately, the company has received a new credit facility from its three main owners, securing financing until February 2023. We are only making minor adjustments to our forecasts and valuation, which still indicates some potential in the share.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/